EIP Pharma presented results from the AscenD-LB phase 2 clinical study of their oral drug, neflamapimod, in mild-to-moderate dementia with Lewy bodies. Results demonstrated that…
A UMass Lowell researchers received $2.7 million to investigate just how Alzheimer’s disease actually evolves. Funded by the NIH’s National Institute on Aging, Electrical, and…
Although the clinical data associated with the recent Alzheimer’s disease drug aducanumab has challenges—the U.S. Food and Drug Administration (FDA) controversially approved the drug, and…
The UK’s Medical Research Council (MRC) awarded £1.5m ($2.07m) to back a study investigating how changes in gene function in targeted brain cells lead to…
A prominent dementia research center based in Cleveland, Ohio secured $15.4 million from the National Institute on Aging, part of the National Institutes of Health…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
